Evidence map›Paper›PMID 28729729›Full record

ArticleScientific reports2017

A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials.

Joshua S Niedzielski, Jinzhong Yang, Francesco Stingo, Zhongxing Liao, Daniel Gomez, Radhe Mohan, Mary Martel, Tina Briere, Laurence Court

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Multiomic random forest toxicity modeling of radiation esophagitis.Physics and imaging in radiation oncology · 2025
    Article
  3. Article
  4. Artificial intelligence to predict outcomes of head and neck radiotherapy.Clinical and translational radiation oncology · 2023
    Article
  5. Early Prediction of Acute Esophagitis for Adaptive Radiation Therapy.International journal of radiation oncology, biology, physics · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joshua S NiedzielskiDepartment of Radiation Oncology, The University of Colorado-School of Medicine, Aurora, Colorado, USA. Joshua.Niedzielski@ucdenver.edu.ORCID 0000-0002-7666-5039
Jinzhong YangDepartment of Radiation Physics, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-9254-4501
Francesco StingoDepartment of Statistics, Computer Science, Applications "G. Parenti", University of Florence, Florence, Italy.ORCID 0000-0001-9150-8552
Zhongxing LiaoDepartment of Radiation Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.
Daniel GomezDepartment of Radiation Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.
Radhe MohanDepartment of Radiation Physics, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.
Mary MartelDepartment of Radiation Physics, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.
Tina BriereDepartment of Radiation Physics, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0001-5829-3991
Laurence CourtDepartment of Radiation Physics, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.

Funding

MDACC Clinical and Research Physics SupportU19CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2014 to 2018
$11.2M
NCI NIH HHS U19 CA021239
6 · The paper itself

Abstract

Personalized cancer therapy seeks to tailor treatment to an individual patient's biology. Therefore, a means to characterize radiosensitivity is necessary. In this study, we investigated radiosensitivity in the normal esophagus using an imaging biomarker of radiation-response and esophageal toxicity, esophageal expansion, as a method to quantify radiosensitivity in 134 non-small-cell lung cancer patients, by using K-Means clustering to group patients based on esophageal radiosensitivity. Patients within the cluster of higher response and lower dose were labelled as radiosensitive. This information was used as a variable in toxicity prediction modelling (lasso logistic regression). The resultant model performance was quantified and compared to toxicity prediction modelling without utilizing radiosensitivity information. The esophageal expansion-response was highly variable between patients, even for similar radiation doses. K-Means clustering was able to identify three patient subgroups of radiosensitivity: radiosensitive, radio-normal, and radioresistant groups. Inclusion of the radiosensitive variable improved lasso logistic regression models compared to model performance without radiosensitivity information. Esophageal radiosensitivity can be quantified using esophageal expansion and K-Means clustering to improve toxicity prediction modelling. Finally, this methodology may be applied in clinical trials to validate pre-treatment biomarkers of esophageal toxicity.

Indexed as

BiomarkersRadiation ToleranceTomography, X-Ray ComputedAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungClinical Trials as TopicEsophagusFemaleHumansLung NeoplasmsMaleMiddle AgedModels, TheoreticalNeoplasm StagingBiomarkers

Identifiers

PMID28729729
PMCPMC5519548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.